HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 86675689, compound → (S)-2-[1-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-5-(4-methanesulfonyl-phenyl)-2-methyl-2,3-dihydro-furo[2,3-c]pyridine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 86675689 | HCID 86675689 | — |
| Reactant | HCID 178449908 | HCID 178449908 | — |
| Product | (S)-2-[1-(3-Isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-5-(4-methanesulfonyl-phenyl)-2-methyl-2,3-dihydro-furo[2,3-c]pyridine | HCID 71208575 | — |
Reaction Steps
The title compound is prepared from (S)-4-[5-(4-methanesulfonyl-phenyl)-2-methyl-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carbonitrile (Intermediate 33; the configuration of the stereocenter is arbitrarily assigned) and N-hydroxy-isobutyramidine following a procedure analogous to that described in Example 2. LC (method 4): tR=1.13 min; Mass spectrum (ESI+): m/z=483 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08778926B2 |
| Source dataset | uspto-grants-2014_07 |
| ORD ID | ord-ff3fd974e1eb431392327d2cd68870e6 |
| Source note | uspto-grants-2014_07 |